
	Three months ended June 30, 2026						Three months ended June 30, 2025
	U.S. dialysis		Other — Ancillary services		Consolidated		U.S. dialysis		Other — Ancillary services		Consolidated
Dialysis patient service revenues:
Medicare and Medicare Advantage	$	1,749,289	$		$	1,749,289	$	1,659,607	$		$	1,659,607
Medicaid and Managed Medicaid	226,944				226,944		217,699				217,699
Other government	88,848		236,377		325,225		83,104		224,937		308,041
Commercial	940,228		136,052		1,076,280		947,015		91,225		1,038,240
Other revenues:
Medicare and Medicare Advantage			151,824		151,824				140,149		140,149
Medicaid and Managed Medicaid			—		—				—		—
Commercial			6,241		6,241				8,322		8,322
Other(1)	6,514		26,215		32,729		5,966		21,054		27,020
Eliminations of intersegment revenues	(11,361)		(3,087)		(14,448)		(16,716)		(2,836)		(19,552)
Total	$	3,000,462	$	553,622	$	3,554,084	$	2,896,675	$	482,851	$	3,379,526


	Six months ended June 30, 2026						Six months ended June 30, 2025
	U.S. dialysis		Other — Ancillary services		Consolidated		U.S. dialysis		Other — Ancillary services		Consolidated
Dialysis patient service revenues:
Medicare and Medicare Advantage	$	3,424,703	$		$	3,424,703	$	3,268,625	$		$	3,268,625
Medicaid and Managed Medicaid	439,773				439,773		424,208				424,208
Other government	181,788		484,556		666,344		159,850		435,301		595,151
Commercial	1,894,471		245,716		2,140,187		1,871,903		178,427		2,050,330
Other revenues:
Medicare and Medicare Advantage			260,331		260,331				239,103		239,103
Medicaid and Managed Medicaid			—		—				2		2
Commercial			9,889		9,889				11,023		11,023
Other(1)	12,790		53,823		66,613		11,974		36,654		48,628
Eliminations of intersegment revenues	(31,833)		(6,375)		(38,208)		(28,450)		(5,565)		(34,015)
Total	$	5,921,692	$	1,047,940	$	6,969,632	$	5,708,110	$	894,945	$	6,603,055

(1) Consists primarily of management service fees in the Company's U.S. dialysis business and research fees, management fees, and other non-patient service revenues in the Other - ancillary services businesses.